The Dermatologist


Topix Pharmaceuticals, Inc. has launched its next-generation BB cream- Replenix UltiMATTE Perfection SPF 50+. The tinted sunscreen is formulated with 16.2% micronized zinc oxide to keep skin firm, sheer and healthy. With Universal Pigment Technology, the BB cream combines iron oxide with an advanced light-diffusing pigment that blends with all skin tones. The multitasking tinted sunscreen moisturizes, conceals and protects skin, while providing gentle hydration…
June, 2015



Topix Pharmaceuticals, Inc. introduces Replenix UltiMATTE Perfection SPF 50+, Tinted Physical Sunscreen — Formulated with 16.2% micronized zinc oxide, to cover the broadest range of the UV protective spectrum, this SPF 50+ skin perfecting cream helps fight photo damage, which leads to premature skin aging. Featuring Universal Pigment Technology, this next generation BB cream combines Iron Oxide with an advanced light-diffusing pigment that blends with all skin tones…
June, July 2015

Latest Product Updates

Citrix® CRS L-Ascorbic Acid Serum

Topix Pharmaceuticals, Inc. is pleased to announce the addition of plant-derived growth factors and collagen building peptides to its advanced formula Citrix® CRS L-Ascorbic Acid Serum. These proven ingredients help to strengthen, fortify and support new collagen to help rebuild the dermal layer. The advanced collagen rejuvenation system reduces the appearance of fine lines and wrinkles and age spots and improves skin texture, tone, and overall appearance.

This advanced Vitamin C system features other high performance ingredients such as Tri-peptides to aid in increased collagen production and Apple and Citrus Stem Cells for intensive micronutrient support, essential for healthy collagen.

The new Citrix® CRS serum is available in 10, 15 and 20% concentrations of this collagen-building antioxidant offering physicians a step-up program to further customize their regimens. This lightweight, fast-absorbing formula is gluten, paraben, oil, alcohol, surfactant, and fragrance free.

Practical Dermatology


Therapeutics Update
Topix Pharmaceuticals, Inc. introduced Replenix® MD Perfect 10 Peel Universal, an in-office aesthetic treatment designed for all skin types as well as first-time peel patients, according to the company. The peel comes in three strengths- Universal, Intermediate, and Advanced-and contains a synergistic blend of potent ingredients that visibly reduce the signs of aging with one peel session..
.July, 2013



Product Reviews
Lightweight and hydroquinone-free ReBrightalyze Enhancement Therapy Lotion from Topix Pharmaceuticals combines silymarin, ascorbic acid, emblica, vitamin E and curcuminoids to protect and calm skin; and tetrahexyldecyl ascorbate, kojic acid, arbutin and bearberry to brighten skin and fade the appearance of dark spots.
July/August, 2013

Men’s Folio


The Grooming Agenda
Using a sunscreen’s good but pairing it with an antioxidant serum will help elevate and boost the protection. […] My latest find is the pretty amazing Topix Replenix® Sheer Physical Sunscreen Cream SPF 50+. It is oil and alcohol free and contains not just one but five antioxidants. So here’s to not letting premature aging win.
September, 2013

Dermatology Times


New Products
Replenix® MD Perfect 10 Peels are medical-grade in-office aesthetic treatments reportedly formulated to reduce the signs of aging. The Replenix® MD Perfect 10 peel system offers both intermediate and advanced acid strengths and is formulated with soothing antioxidants, the company states. In five steps, patients will see smoother and younger-looking skin.
January, 2013



The latest product news and technologies for the aesthetic and anti-ageing market Topix Pharmaceuticals, Inc. introduces Replenix® MD Perfect 10 Peels – medical grade, in-office aesthetic treatments designed to provide maximum, predictable and noticeable results.
January, 2013



Hang Ten
Topix Pharmaceuticals Inc’s new Replenix® MD Perfect 10 Peels may be just what the doctor ordered. The in-office treatments promise to reduce the signs of aging with just one session.
January, 2013